Lionel Carnot

Lionel Carnot is a seasoned professional in the healthcare investment sector, currently serving as a Partner at Earlybird Venture Capital since March 2012 and as Managing Director at Bay City Capital LLC since 2005. In addition to these roles, Lionel Carnot holds various board positions, including Board Member at iSTAR Medical and Oculis ehf., and Member of the Board of Directors at iQone Healthcare Switzerland. Past board memberships include Atlantic Therapeutics, Merus, Interleukin Genetics, Madrigal Pharmaceuticals Inc., and Nabsys. Lionel Carnot obtained an MBA from INSEAD in 1995 and a Master of Science in Molecular Biology from the University of Geneva in 1988, complemented by a Maturite - Abitur from the International School of Geneva, La Chataigneraie.